Signant joined a group of C-Path members including other eCOA solution providers, sponsors, and regulators for a GBTI project that revealed several opportunities to improve eCOA usability and flexibility.

Choosing an eCOA provider can be daunting and time consuming, while adhering to the timelines and needs of your study. Learn how an eCOA solution, backed by a DCT platform, can be a benefit to your study.

In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.

It’s apparent to those who have used it that the “e” in eConsent could stand for much more than 'electronic'. Duke’s new research shows why participants prefer an eConsent experience bolstered with videos, media, questions, and more.

The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.

Understand the gaps between how data is collected in real-world evidence (RWE) and randomized clinical trials (RCT) and how RWE is quickly finding ways to catch up.

The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.

Bridge the gap between clinic and home with flexible data capture. Use any device to ensure consistent, real-time data entry and improve compliance throughout the study lifecycle.

eCOA solutions enhance data quality in clinical trials by preventing common issues in paper-based COA data, such as missing, ambiguous, or conflicting entries, and ensuring reliable data collection.